Page 3 - Johnson Medtech News Today

Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The

Recent earnings reports from Intuitive Surgical and Johnson & Johnson highlight the surging demand for robotic-assisted solutions.

Johnson & Johnson's Biosense Webster unit today announced positive three-month follow-up results from its SmartfIRE clinical trial.

/PRNewswire/ -- HealthQuest Capital, a private asset firm that provides capital to transformative healthcare companies, today announced the addition of Ashley...

Inari, among the area’s faster-growing public companies since going public in 2020, recently announced plans to invest a minimum of $15 million in a new manufacturing facility in Grecia, Costa Rica.

Johnson & Johnson acquires Shockwave Medical, bolstering its presence in cardiovascular intervention. The move marks a strategic shift, with around $30 billion invested in MedTech over 18 months.

Johnson & Johnson JNJ agreed on Friday to acquire Shockwave Medical Inc SWAV for $335 per share in cash, corresponding to an enterprise value of approximately…

Johnson & Johnson (NYSE: JNJ) announced today that it agreed to acquire Shockwave Medical (Nasdaq:SWAV) for approximately $13.1 billion.

Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in...

Johnson & Johnson to acquire Shockwave Medical for $335.00/share in cash, bolstering its cardiovascular intervention portfolio. The acquisition, expected to close by mid-2024, signifies Johnson & Johnson's strategic focus on innovation and market expansion.